3,604
Views
8
CrossRef citations to date
0
Altmetric
Original Research Article

Health-related quality of life in young women starting hormonal contraception: a pilot study

, &
Pages 171-178 | Received 01 Oct 2017, Accepted 18 Mar 2018, Published online: 19 Apr 2018

References

  • Frye CA. An overview of oral contraceptives: mechanism of action and clinical use. Neurology. 2006;66(6 Suppl. 3):S29–S36.
  • Kaunitz AM. Oral contraceptive health benefits: perception versus reality. Contraception. 1999;59(1 Suppl):29S–33S.
  • Wallwiener CW, Wallwiener LM, Seeger H, et al. Sexual function, contraception, relationship, and lifestyle in female medical students. J Women’s Health (Larchmt). 2017;26:169–177.
  • Hatcher RA, Trussell J, Stewart F, et al. Contraceptive technology. 20th rev. ed. New York (NY): Ardent Media; 2011.
  • Lundin C, Gemzell Danielsson K, Bixo M, et al. Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle – a double-blind, placebo-controlled randomized trial. Psychoneuroendocrinology. 2016;76:135–143.
  • Poromaa IS, Segebladh B. Adverse mood symptoms with oral contraceptives. Acta Obstet Gynecol Scand. 2012;91:420–427.
  • Kulkarni J. Depression as a side effect of the contraceptive pill. Expert Opin Drug Saf. 2007;6:371–374.
  • Rubinow DR, Schmidt PJ, Roca CA. Estrogen–serotonin interactions: implications for affective regulation. Biol Psychiatry. 1998;44:839–850.
  • Ware JE Jr, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol. 1998;51:903–912.
  • World Health Organization [Internet]. Constitution of WHO: principles; 2018. Available from: www.who.int/about/mission/en/
  • Kristjansdottir J, Olsson GI, Sundelin C, et al. Could SF-36 be used as a screening instrument for depression in a Swedish youth population? Scand J Caring Sci. 2011;25:262–268.
  • Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389.
  • Kristjansdottir J, Olsson GI, Sundelin C, et al. Self-reported health in adolescent girls varies according to the season and its relation to medication and hormonal contraception – a descriptive study. Eur J Contracept Reprod Health Care. 2013;18: 343–354.
  • Gupta N, O’Brien R, Jacobsen LJ, et al. Mood changes in adolescents using depot-medroxyprogesterone acetate for contraception: a prospective study. J Pediatr Adolesc Gynecol. 2001; 14:71–76.
  • The Swedish Society for Youth Centres [Internet]. Guidelines for Swedish youth centres; 2018. Available from: www.fsum.org/fsum/wp-content/uploads/2011/02/guidelines_2.pdf
  • Sullivan M, Karlsson J, Taft C, editors. SF-36 Hälsoenkät. Svensk Manual och Tolkningsguide 2: a upplagan. Gothenburg: Sahlgrenska University Hospital; 2002.
  • Ware JE Jr, SF-36 health survey update. Spine (Phila Pa 1976). 2000;25:3130–3139.
  • Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive developmental model for major depression in women. Am J Psychiatry. 2002;159:1133–1145.
  • Hall KS, Moreau C, Trussell J, et al. Role of young women's depression and stress symptoms in their weekly use and nonuse of contraceptive methods. J Adolesc Health. 2013;53: 241–248.
  • Weisberg E, McGeehan K, Fraser IS. Effect of perceptions of menstrual blood loss and menstrual pain on women's quality of life. Eur J Contracept Reprod Health Care. 2016;21:431–435.
  • Tonetti L, Barbato G, Fabbri M, et al. Mood seasonality: a cross-sectional study of subjects aged between 10 and 25 years. J Affect Disord. 2007;97:155–160.
  • Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol. 1998;179:577–582.
  • Sawyer SM, Drew S, Yeo MS, et al. Adolescents with a chronic condition: challenges living, challenges treating. Lancet. 2007; 369:1481–1489.
  • Chi C, Pollard D, Tuddenham EG, et al. Menorrhagia in adolescents with inherited bleeding disorders. J Pediatr Adolesc Gynecol. 2010;23:215–222.
  • Hogberg G, Gustafsson SA, Hallstrom T, et al. Depressed adolescents in a case-series were low in vitamin D and depression was ameliorated by vitamin D supplementation. Acta Paediatr. 2012;101:779–783.
  • Zhang HQ, Teng JH, Li Y, et al. Vitamin D status and its association with adiposity and oxidative stress in schoolchildren. Nutrition. 2014;30:1040–1044.
  • Deecher D, Andree TH, Sloan D, et al. From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology. 2008;33:3–17.
  • Newhouse P, Albert K. Estrogen, stress, and depression. A neurocognitive model. JAMA Psychiatry. 2015;72:727–729.
  • Krzywanski J, Mikulski T, Krysztofiak H, et al. Seasonal vitamin D status in Polish elite athletes in relation to sun exposure and oral supplementation. PLoS One. 2016;11:e0164395.
  • Swedish Meteorological and Hydrological Institute. Normal sunshine for one year [Internet]; 2017. Available from: www.smhi.se/klimatdata/meteorologi/stralning/normal-solskenstid-for-ett-ar-1.3052
  • Parker GB, Brotchie H, Graham RK. Vitamin D and depression. J Affect Disord. 2017;208:56–61.
  • Kerr DC, Zava DT, Piper WT, et al. Associations between vitamin D levels and depressive symptoms in healthy young adult women. Psychiatry Res. 2015;227:46–51.
  • Lindberg M, Foldemo A, Josefsson A, et al. Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses. Eur J Contracept Reprod Health Care. 2012;17:106–118.
  • Toffoletto S, Lanzenberger R, Gingnell M, et al. Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: a systematic review. Psychoneuroendocrinology. 2014;50:28–52.
  • Costello EJ, Mustillo S, Erkanli A, et al. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry. 2003;60:837–484.
  • Bengtsdotter H, Lundin C, Gemzell Danielsson K, et al. Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use. Eur J Contracept Reprod Health Care. 2018;23:45–51.
  • Skovlund CW, Morch LS, Kessing LV, et al. Association of hormonal contraception with depression. JAMA Psychiatry. 2016;73:1154–1162.
  • Nygaard Andersen M, Bech P, Csillag C. Development and remission of depressive symptoms and treatment with hormonal contraceptives. Oxf Med Case Rep. 2014;2014:63–64.
  • Dragoman MV. The combined oral contraceptive pill – recent developments, risks and benefits. Best Pract Res Clin Obstet Gynaecol. 2014;28:825–834.
  • Melrose S. Seasonal affective disorder: an overview of assessment and treatment approaches. Depress Res Treat. 2015;2015: 178564.
  • Stadje R, Dornieden K, Baum E, et al. The differential diagnosis of tiredness: a systematic review. BMC Fam Pract. 2016;17:147.
  • Swedish National Board of Health and Welfare [Internet]. Abortion statistics; 2015. Available from: www.socialstyrelsen.se/publikationer2016/2016-5-20
  • Swedish National Board of Health and Welfare [Internet]. Statistics database for medicines; 2018. Available from: www.socialstyrelsen.se/statistik/statistikdatabas/lakemedel
  • Husmann C, Frank M, Schmidt B, et al. Low 25(OH)-vitamin D concentrations are associated with emotional and behavioral problems in German children and adolescents. PLoS One. 2017; 12:e0183091.